AbCellera Results Presentation Deck

2020 FULL YEAR FINANCIAL RESULTS OPERATING EXPENSES REFLECT CONTINUED STRENGTHENING OF THE PLATFORM & NON-RECURRING COSTS Operating Expenses USD RESEARCH & DEVELOPMENT $10.1M 2019 +$11M $29.4M $4.3M $4.0M 2020 LCO OrthoMabTM SALES & MARKETING $1.3M 2019 +$2.6M $3.8M 2020 GENERAL & ADMIN $2.7M 2019 +$7.3M $11.9M $1.9M 2020 Ab Cellera Preferred share financing and IPO COPYRIGHT ABCELLERA 19

View entire presentation